Get this report today!
Table of Contents
The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if not longer. Because of this, major pharmaceutical marketers continue to outsource stages of development, and over the years Kalorama Information has observed this process. In past editions of our outsourcing market studies, we found that outsourcing moved from "should" to "must." for manufacturers. This trend has only continued in the past two years.
Contract Research Organizations (CROs) and other entities can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to market is ever-increasing and intensifying. A key cost driver is the large number of failures during the expensive clinical trial phases. Driven by pressures to reduce costs, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry.
Kalorama Information's Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market is the third edition of this study of the drivers for outsourcing drug development, the companies involved in this market and the opportunity for revenues.
As part of its comprehensive coverage of this market, this report contains:
Talk to Louis
+1 718 618 4302
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics)and ...
The Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery, preclinical and ...
This report encompasses market estimations for biopreservation market for the forecast period 2013 to 2019. The market size is forecasted considering 2012 as the base year and is represented in terms of ...
... Complexities, and so on). Within the cro market, the largest segment was that of drug discovery. Based on various analyses, the report also anticipates that the market for clinical data management services ...
... Learn/confirm and predict phase vi registering and labeling (maa) uncertainty confident and drug and disease paediatric strategy & investigation plan scientific advice clinical trial ...
... Company. The transaction positions telerx for further expansion of one of its key vertical businesses 8 nov 12 smo n/a augment number of clinical trial sites to 57. Increase access to patients, conduct ...
Reportlinker.com © Copyright 2014. All rights reserved.